Commonly prescribed GLP-1 medications in the UK include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide products
Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma
Report any adverse reactions via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk) to contribute to medication safety surveillance
However, if the reaction represents true sensitivity to Retatrutide, changing suppliers will not prevent it
Weight loss results vary by individual, but in clinical studies, people taking GLP-1 Treatments, Semaglutide or Tirzepatide for weight loss have lost, on average, 10-15% of their body weight over a 6-month to 1-year period